Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.85 |
| ▸ | BAD | Q92934 | 1/20 | 0.85 |
| ▸ | TSHR | P16473 | 3/20 | 0.71 |
| ▸ | TP53 | P04637 | 1/20 | 0.71 |
| ▸ | MITF | O75030 | 1/20 | 0.65 |
| ▸ | CES2 | O00748 | 2/20 | 0.65 |
| ▸ | CES1 | P23141 | 2/20 | 0.65 |
| ▸ | SRD5A2 | P31213 | 2/20 | 0.60 |
| ▸ | CA1 | P00915 | 4/20 | 0.59 |
| ▸ | CA2 | P00918 | 4/20 | 0.59 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.59 |
| ▸ | CA12 | O43570 | 1/20 | 0.57 |
| ▸ | CA3 | P07451 | 1/20 | 0.57 |
| ▸ | TYR | P14679 | 1/20 | 0.57 |
| ▸ | DRD1 | P21728 | 1/20 | 0.57 |
| ▸ | CA4 | P22748 | 1/20 | 0.57 |
| ▸ | CA6 | P23280 | 1/20 | 0.57 |
| ▸ | CA5A | P35218 | 1/20 | 0.57 |
| ▸ | CA7 | P43166 | 1/20 | 0.57 |
| ▸ | CA9 | Q16790 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27498 | 1.00 | BCL2L1 (0.85) | BCL2L1BADTSHRTP53MITF | |
| SCHEMBL18670950 | 1.00 | BCL2L1 (0.85) | BCL2L1BADTSHRTP53MITF | |
| SCHEMBL11452380 | 0.97 | BCL2L1 (0.81) | BCL2L1BADTSHRTP53MITF | |
| Methane SCHEMBL6203577 | 0.97 | BCL2L1 (0.81) | BCL2L1BADTSHRTP53MITF | |
| SCHEMBL17332097 | 0.97 | BCL2L1 (0.81) | BCL2L1BADTSHRTP53MITF | |
| SCHEMBL17332135 | 0.97 | BCL2L1 (0.81) | BCL2L1BADTSHRTP53MITF | |
| Fluoride SCHEMBL10732554 | 0.97 | BCL2L1 (0.81) | BCL2L1BADTSHRTP53MITF | |
| Ammonia Solution, Strong SCHEMBL4465466 | 0.97 | BCL2L1 (0.81) | BCL2L1BADTSHRTP53MITF | |
| SCHEMBL22734857 | 0.97 | BCL2L1 (0.81) | BCL2L1BADTSHRTP53MITF | |
| SCHEMBL10607654 | 0.97 | BCL2L1 (0.81) | BCL2L1BADTSHRTP53MITF |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240279225-A1 | COMPOUNDS AND METHODS FOR THERANOSTIC TARGETING OF PARP ACTIVITY | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2024-08-22 | — | — | US | disclosed |
| US-12023391-B2 | Alpha(v)beta(6) integrin-binding peptides and methods of use thereof | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2024-07-02 | — | — | US | disclosed |
| US-20240101601-A1 | BI-TERMINAL PEGYLATED INTEGRIN-BINDING PEPTIDES AND METHODS OF USE THEREOF | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2024-03-28 | — | — | US | disclosed |
| CN-110662759-B | Tumor targeting peptide variants | 癌症研究技术有限公司 | 2024-03-08 | — | — | CN | disclosed |
| EP-4319755-A1 | COMPOUNDS AND METHODS FOR THERANOSTIC TARGETING OF PARP ACTIVITY | Board of Regents, The University of Texas System (US) | 2024-02-14 | — | — | EP | disclosed |
| US-20230183317-A1 | METHODS OF DETECTING AND TREATING LUNG DAMAGE IN RESPIRATORY-RELATED VIRAL INFECTIONS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2023-06-15 | — | — | US | disclosed |
| EP-4146268-A2 | METHODS OF DETECTING AND TREATING LUNG DAMAGE IN RESPIRATORY-RELATED VIRAL INFECTIONS | The Regents of the University of California (US) | 2023-03-15 | — | — | EP | disclosed |
| US-11591369-B2 | Alpha(v)beta(6) integrin-binding peptides and methods of use thereof | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2023-02-28 | — | — | US | disclosed |
| US-11485758-B2 | Bi-terminal pegylated integrin-binding peptides and methods of use thereof | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2022-11-01 | — | — | US | disclosed |
| WO-2022216979-A1 | COMPOUNDS AND METHODS FOR THERANOSTIC TARGETING OF PARP ACTIVITY | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2022-10-13 | — | — | WO | disclosed |
| US-20110144344-A1 | FLUORIDATION OF IODONIUM SALTS | GE HEALTHCARE LIMITED (GB) | 2011-06-16 | — | — | US | disclosed |
| US-7935852-B2 | Fluoridation method | GE HEALTHCARE LIMITED (GB) | 2011-05-03 | — | — | US | disclosed |
| US-7919579-B2 | Imaging and therapeutic targeting of prostate and bladder tissues | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2011-04-05 | — | — | US | disclosed |
| US-20100322854-A1 | POSITRON EMISSION TOMOGRAPHY IMAGING METHOD | PURDUE RESEARCH FOUNDATION (US) | 2010-12-23 | — | — | US | disclosed |
| US-20100111838-A1 | BRAIN-LOCALIZING POLYPEPTIDES COMPRISING A MULTIVALENT BINDING MOIETY AND IMPROVED METABOLIC STABILITY | PROTEUS SCIENCES CO., LTD (JP) | 2010-05-06 | — | — | US | disclosed |
| US-7642373-B2 | Forming for example [18F]-dopamine or [18F]-uracil via reaction of iodonium salt precursor, where use of free radical scavenger improves yield of aryl fluoride | GE HEALTHCARE LIMITED (GB) | 2010-01-05 | — | — | US | disclosed |
| US-20090123381-A1 | IMAGING AND THERAPEUTIC TARGETING OF PROSTATE AND BLADDER TISSUES | US ARMY, SECRETARY OF THE ARMY | 2009-05-14 | — | — | US | disclosed |
| US-20080248485-A1 | Radiolabeled 3-[3- (Benzoyl-Amido) Benzyloxy] Aspartic Acid Derivative and Method of Producing the Same | SUNTORY HOLDINGS LIMITED (JP) | 2008-10-09 | — | — | US | disclosed |
| US-20070276231-A1 | Positron Emission Tomography Imaging Method | PURDUE RESEARCH FOUNDATION | 2007-11-29 | — | — | US | disclosed |
| US-20070092441-A1 | Fluoridation method | GE HEALTHCARE LIMITED (GB) | 2007-04-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070092441-A1 | Fluoridation method | FLNB, FLNA, ARFGEF1 | BCL2L1 4436/4885BAD 4427/4885TSHR 242/4885 |
| US-20240279225-A1 | COMPOUNDS AND METHODS FOR THERANOSTIC TARGETING OF PARP ACTIVITY | PARP8, PARP1, PARP3 | BCL2L1 2083/4885BAD 34/4885TSHR 1586/4885 |
| US-20110144344-A1 | FLUORIDATION OF IODONIUM SALTS | ARF5, IPO5, SAMHD1 | BCL2L1 3873/4885BAD 1288/4885TSHR 42/4885 |
| US-20230183317-A1 | METHODS OF DETECTING AND TREATING LUNG DAMAGE IN RESPIRATORY-RELATED VIRAL INFECTIONS | ACE2, ACE, MAVS | BCL2L1 1721/4885BAD 4549/4885TSHR 3168/4885 |
| US-20080248485-A1 | Radiolabeled 3-[3- (Benzoyl-Amido) Benzyloxy] Aspartic Acid Derivative and Method of Producing the Same | SLC1A1, SLC1A5, SLC1A3 | BCL2L1 4778/4885BAD 4004/4885TSHR 515/4885 |
| US-20090123381-A1 | IMAGING AND THERAPEUTIC TARGETING OF PROSTATE AND BLADDER TISSUES | ADM2, DAB2IP, ARG2 | BCL2L1 1940/4885BAD 319/4885TSHR 2683/4885 |
| US-20100111838-A1 | BRAIN-LOCALIZING POLYPEPTIDES COMPRISING A MULTIVALENT BINDING MOIETY AND IMPROVED METABOLIC STABILITY | FABP7, PYGB, DCX | BCL2L1 3670/4885BAD 4768/4885TSHR 2718/4885 |
| US-20100322854-A1 | POSITRON EMISSION TOMOGRAPHY IMAGING METHOD | VDR, FOLR2, SLC46A1 | BCL2L1 3588/4885BAD 3994/4885TSHR 287/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.